Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
UBS
QuintilesIMS
Healthtrust
Merck
Colorcon
Teva
Cipla
Fish and Richardson
Chinese Patent Office

Generated: August 19, 2017

DrugPatentWatch Database Preview

PROMETHAZINE VC W/ CODEINE Drug Profile

« Back to Dashboard

What is the patent landscape for Promethazine Vc W/ Codeine, and when can generic versions of Promethazine Vc W/ Codeine launch?

Promethazine Vc W/ Codeine is a drug marketed by Cenci and Wockhardt and is included in two NDAs.

The generic ingredient in PROMETHAZINE VC W/ CODEINE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.

Summary for Tradename: PROMETHAZINE VC W/ CODEINE

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list1
Clinical Trials: see list150
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROMETHAZINE VC W/ CODEINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cenci
PROMETHAZINE VC W/ CODEINE
codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride
SYRUP;ORAL088816-001Nov 22, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Wockhardt
PROMETHAZINE VC W/ CODEINE
codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride
SYRUP;ORAL088896-001Jan 4, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Argus Health
US Army
Baxter
Queensland Health
Federal Trade Commission
Citi
McKinsey
Healthtrust
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot